Marker Therapeutics Says 'MultiTAA-specific T Cell Therapies Demonstrate Clinical Safety and Positive Clinical Data Across Multiple Indications'
Marker Therapeutics表示 “Multitaa特异性T细胞疗法在多个适应症中显示出临床安全性和积极的临床数据”
Marker Therapeutics Says 'MultiTAA-specific T Cell Therapies Demonstrate Clinical Safety and Positive Clinical Data Across Multiple Indications'
Marker Therapeutics表示 “Multitaa特异性T细胞疗法在多个适应症中显示出临床安全性和积极的临床数据”
使用浏览器的分享功能,分享给你的好友吧